|
Decades of experience, strong patient support, and more.
|
|
|
|
|
|
NovoSeven®
RT is used to treat bleeding episodes in people
with hemophilia A or B with inhibitors,
congenital Factor VII deficiency, Glanzmann’s
thrombasthenia with resistance to platelets, and
acquired hemophilia.
|
|
|
|
|
Trusted for over 30 years
|
|
NovoSeven®
RT was the first recombinant factor VIIa (rFVIIa) therapy
approved for hemophilia A and B with inhibitors, and it’s
the only rFVIIa treatment approved for all
ages—children, adolescents, and adults.
|
|
|
|
|
Bob, Chase and Sid live
with hemophilia A with inhibitors.
Miguel lives with hemophilia B with
inhibitors.
|
|
Scroll to learn whether NovoSeven®
RT is right for you.
|
|
|
|
Selected Important Safety Information
|
|
What is the most important information I should
know about NovoSeven® RT?
|
|
NovoSeven® RT may cause serious side effects,
including:
|
| |
•
|
Serious blood clots that form
in veins and arteries with the use
of NovoSeven® RT have been reported
|
|
| |
•
|
Your healthcare provider should
discuss the risks and explain the
signs and symptoms of blood clots to
you. Some signs of a blood clot may
include pain, swelling, warmth,
redness, or a lump in your legs or
arms, chest pain, shortness of
breath, or sudden severe headache
and/or loss of consciousness or
function
|
|
| |
•
|
Your healthcare provider should
monitor you for blood clots during
treatment with NovoSeven® RT
|
|
|
Please
click here
or scroll below for additional Important Safety
Information.
|
|
|
|
|
Important “factors” you should know about
|
|
NovoSeven®
RT offers fast bleed control for even the most
life-threatening bleedsa—it’s 90% effective in all severe bleeding
episodes.b
And, it has a
proven safety profile for use before, during, and after
surgery.
|
|
|
aIn
compassionate use situations including surgery, central
nervous system hemorrhages, severe intra-abdominal bleeding,
and other life-threatening bleeding episodes.
bFor
hemophilia patients with inhibitors. Data shown from
compassionate use program and 2 clinical studies.
|
|
|
|
Dosing designed
with you in mind
|
|
NovoSeven®
RT is available in 4 vial sizes, more than any other rFVIIa
therapy, so you might need fewer vials to infuse your dose.
And, you can infuse quickly, in 2-5 minutes.c
|
|
|
|
cAdminister as a slow bolus injection over 2-5 minutes,
depending on the dose administered.
|
|
|
|
|
Get support when you need it
|
|
We offer comprehensive, personalized support so
you can focus on enjoying your life. With
NovoSecure™, you’ll receive:
|
-
One-on-one access to a NovoSecure™
Specialist
-
Financial product assistance
- Educational resources
|
|
|
|
|
|
|
What is NovoSeven® RT?
|
|
NovoSeven® RT (coagulation Factor VIIa, recombinant) is an
injectable medicine used for:
|
| |
•
|
Treatment of bleeding and prevention of bleeding
for surgeries and procedures in adults and
children with hemophilia A or B with inhibitors,
congenital Factor VII (FVII) deficiency, and
Glanzmann’s thrombasthenia with a decreased or
absent response to platelet transfusions
|
|
| |
•
|
Treatment of bleeding and prevention of bleeding
for surgeries and procedures in adults with
acquired hemophilia
|
|
|
Important Safety Information (cont’d)
|
| |
•
|
You should not use NovoSeven® RT if you have ever had allergic
(hypersensitivity) reactions, including severe,
whole body reactions (anaphylaxis) to
NovoSeven® RT, any of its ingredients, or mice,
hamsters, or cows. Signs of allergic reaction
include shortness of breath, rash, itching
(pruritus), redness of the skin (erythema), or
fainting/dizziness
|
|
|
What should I tell my healthcare provider before using
NovoSeven® RT?
|
| |
•
|
Tell your healthcare provider if you have any of
the following, as these may increase your risk
of blood clots:
|
| |
|
| |
◦
|
congenital hemophilia and are also
receiving treatment with aPCCs
(activated prothrombin complex
concentrates)
|
| |
◦
|
are an older patient particularly
with acquired hemophilia and
receiving other agents to stop
bleeding
|
| |
◦
|
history of heart or blood vessel
diseases
|
|
| |
•
|
Tell your healthcare provider and pharmacist
about all the medicines you take, including all
prescription and non-prescription medicines,
such as over-the-counter medicines, supplements,
or herbal remedies
|
|
|
What are the possible side effects of NovoSeven® RT?
|
| |
•
|
The most common and serious side effects are
blood clots
|
|
| |
•
|
Tell your healthcare provider about any side
effects that bother you or do not go away, and
seek medical help right away if you have signs
of a blood clot or allergic reaction
|
|
|
Please
click here
for Prescribing Information.
|
|
NovoSeven®
RT is a prescription medication.
|
|
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call
1-800-FDA-1088.
|
|
|
|
PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like
to contact us, please
click here
or call
1‑877‑744‑2579.
|
|
UNSUBSCRIBE NOTICE
|
|
If you no longer want to receive communications from
Novo Nordisk, the sponsor of this content, click here to
unsubscribe. You also may call Novo Nordisk at
1.877.744.2579
or send a letter that includes your full contact
information (e.g. name, email address, phone) to Novo
Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey
08536. To better understand how Novo Nordisk values your
privacy, please see the
Privacy Statement.
|
|
NovoSeven®
is a registered trademark and NovoSecure™ is a
trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk
A/S.
© 2020 Novo Nordisk All rights
reserved.
US20NSVN00137
November 2020
|
|
|
|
|